Apogee Therapeutics is a clinical-stage biotechnology company focused on developing novel biologics designed to deliver differentiated efficacy and dosing in the expansive immune and inflammatory (I&I) markets. We cater to patients and healthcare providers seeking innovative treatment options that can address unmet medical needs.
